Hide Board Information

Show Board Information

Scivanta Medical Corp. SCVM

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/16/2014 3:30:01 PM

Board Marks: 1

Posts Today: 0

Board Views Today: 1

Scivanta Medical Corp. (OTCMRKTS: SCVM) Stock Message Board

1. SCVM Company Profile

    

2. SCVM Time & Sales

    

3. SCVM Recent News

    

4. SCVM Filings

    

5. SCVM Financials

    

6. SCVM Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

3	SCVM Financials 07/16/2014 14:30:05 Scivanta	Emylers	07/16/2014 3:30:01 PM
2	SCVM 0.13 Stock Charts $SCVM 1 Month Chart	chartguy89	03/09/2014 5:39:17 PM
1	SCVM Stock Charts Last: UNCH Saturday, March 1,	chartguy89	03/01/2014 1:01:05 PM

Recent Articles

• Cathie Wood's Ark Invest Shifts Focus to Baidu from Tesla
• Nidec Corporation Investors: Key Updates and Actions to Take
• Investors Presented with a Class Action Opportunity Against ARE
• Hong Kong Unites After Fire, Showcases Resilience and Hope
• Examining the Worth of Alexander & Baldwin's Shareholder Deal
• Innovative Wellness Gifts from SKG for a Healthier Holiday Season
• TDECU Welcomes New Strategic Leaders to Board for Growth
• EnWave Corporation's Upcoming Q4 2025 Financial Report Plans
• Cygnus Metals Limited Issues Performance Rights to Employees
• Netcapital Inc. Implements New Incentive Program for Growth
• Insights on Alvotech's Class Action Investigation by Rosen Law
• Monument Mining's AGM: Key Highlights and Future Directions
• RetinalGenix Technologies Welcomes M. Cory Zwerling as New CFO
• ALT5 Sigma Corp Faces Investigation Over Securities Concerns
• Legal Alert: DeFi Technologies Class Action Lawsuit Update
• Market Updates: Key Stocks Drawing Investor Interest Today
• Hormel Foods Corporation Investors: Taking Action on Legal Rights
• Investigation on Nidec Corporation: Investors Aware of Claims
• Brookfield Corporation Unveils C$1 Billion Medium-Term Notes
• Marquis Software Faces Data Breach Concerns Affecting Customers
• California Consumers Face $59 Billion Gas Overcharge Crisis
• Cali-Power Football Team Triumphs in Court Over Title Rights
• Ascentage Pharma Showcases Long-Term Efficacy Data for Olverembatinib
• Promising Results from Phase III POLARIS-1 Study of Olverembatinib
• Promising New Data on Olverembatinib for CML Treatment
• Promising Update on Olverembatinib for CML-CP Patients
• Olverembatinib's Significant Long-Term Impact for CML Patients
• CoreWeave, Inc.: Investigating Claims and Market Impact
• Hong Kong Rallies Together to Rebuild After Tragic Fire
• RetinalGenix Welcomes M. Cory Zwerling as New CFO and Interim COO
• Star Group, L.P. Sees Growth in 2025 Financial Results
• Star Group, L.P. Achieves Revenue Growth in Fiscal 2025
• Shaquille O'Neal's Innovative Journey from Basketball to Tech
• BioArctic's Leqembi Listed as Innovative Drug in China
• Innovent Biologics Delivers Breakthrough in Psoriasis Treatment
• Vermilion Energy Expands Financial Strategy Through Share Sales
• Morgan Dudley Joins Stargaze as Creative Advisor for New Era
• Understanding the Securities Class Action for Telix Pharmaceuticals
• Trump's Involvement in Paramount's Bid for Warner Bros. Discovery
• Investing in Deutsche Bank: Strong Returns Over Five Years
• Transform Your Investment: The Journey of $1000 in OEF Growth
• BioArctic's Leqembi Approved for China's Innovative Drug List
• Urgent Call for Global Health Funding to Prevent Child Deaths
• LEQEMBI's Inclusion in China's Innovative Drug List: Impact and Future
• Important Update for Synopsys Investors on Class Action Steps
• JAX's $30 Million Initiative to Transform Drug Safety Testing
• Discover the Growth of a $1000 Investment in Stryker Today
• Gates Foundation Calls for Action to Combat Child Mortality Rise
• Exciting Growth for Club Med: New Resort at Tremblant
• Kia PV5 Cargo: Leading the Charge in Commercial Van Safety